V.F. Corp To Replace ModivCare In S&P SmallCap 600, Effective Prior To The Open Of Trading On April 3
$MODV
Transportation Services
Consumer Discretionary
ModivCare is no longer representative of the small-cap market space
ModivCare is no longer representative of the small-cap market space
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/9/2024 | $35.00 | Mkt Perform → Outperform | Barrington Research |
| 5/6/2024 | $50.00 | Hold → Buy | Lake Street |
| 2/23/2024 | $60.00 → $40.00 | Buy → Hold | Deutsche Bank |
| 2/23/2024 | $60.00 → $39.00 | Buy → Hold | Jefferies |
| 8/3/2022 | $145.00 | Overweight | Stephens |
| 2/28/2022 | $190.00 → $155.00 | Outperform | Barrington Research |
| 2/3/2022 | $180.00 → $150.00 | Buy | Deutsche Bank |
| 12/17/2021 | $180.00 | Buy | Deutsche Bank |
Barrington Research upgraded ModivCare from Mkt Perform to Outperform and set a new price target of $35.00
Lake Street upgraded ModivCare from Hold to Buy and set a new price target of $50.00
Deutsche Bank downgraded ModivCare from Buy to Hold and set a new price target of $40.00 from $60.00 previously
SC 13G - ModivCare Inc (0001220754) (Subject)
SC 13G/A - ModivCare Inc (0001220754) (Subject)
SC 13G/A - ModivCare Inc (0001220754) (Subject)
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
Lake Street analyst Brooks O'Neil upgrades ModivCare (NASDAQ:MODV) from Hold to Buy and maintains $50 price target.
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three and nine months ended September 30, 2024. Third Quarter 2024 Summary: Service revenue of $702.0 million increased 2.2% from the third quarter of 2023 Net loss of $26.6 million, or negative $1.87 per diluted common share Adjusted EBITDA(1) of $43.2 million, adjusted net income(1) of $6.4 million and adjusted EPS(1) of $0.45 per diluted common share Cash provided by operating activities during the quarter of $9.3 million and
Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the third quarter 2024 ended September 30, 2024, on Wednesday, November 6, 2024, after the market closes. Modivcare will host a conference call on Thursday, November 7, 2024, at 8:30 a.m. Eastern Time to discuss third quarter 2024 financial results. The conference call dial-in number for domestic callers is (888) 437-3179, and international callers should dial +1 (862) 298-0702. Interested parties may a
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three and six months ended June 30, 2024. Second Quarter 2024 Summary: Service revenue of $698.3 million, remaining consistent with the second quarter of 2023 Net loss of $128.9 million or negative $9.07 per diluted common share Adjusted EBITDA(1) of $45.4 million, adjusted net loss(1) of $0.4 million and adjusted EPS(1) of negative $0.03 per diluted common share Cash used in operating activities during the quarter of $55.3 mil
NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE:SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE:VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. V.F. will replace ModivCare Inc. (NASD: MODV) in the S&P SmallCap 600 also effective prior to the open of trading on April 3. S&P 500 and 100 constituent 3M Co. (NYSE:MMM) is spinning off Solventum in a transaction expected to be completed April 1. Following the spin-off, the parent 3M will rema
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced the appointment of Jeff Bennett as Chief Strategy and Innovation Officer and Seth Ravine as Chief Commercial Officer, effective December 2023. "I am incredibly excited for the appointment of these two positions, underscoring our commitment to building a top-notch leadership team that will steer Modivcare's strategic course and drive success in this dynamic landscape," said Heath Sampson, President and CEO of Modivcare. "The addition of Jeff and Seth's roles reinfo
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Stacy Saal has stepped down from the Board of Directors in order to dedicate more time to her new professional endeavors. "We are grateful for Stacy's contributions to Modivcare and we wish her the best as she turns to her next chapter and pursues a number of exciting projects," said Chris Shackelton, Chairman of Modivcare's Board of Directors. "From her first day on the Board, Stacy was dedicated to driving value for shareholders. The experience, diligence,
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
8-K - ModivCare Inc (0001220754) (Filer)
8-K - ModivCare Inc (0001220754) (Filer)
EFFECT - ModivCare Inc (0001220754) (Filer)
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three and nine months ended September 30, 2024. Third Quarter 2024 Summary: Service revenue of $702.0 million increased 2.2% from the third quarter of 2023 Net loss of $26.6 million, or negative $1.87 per diluted common share Adjusted EBITDA(1) of $43.2 million, adjusted net income(1) of $6.4 million and adjusted EPS(1) of $0.45 per diluted common share Cash provided by operating activities during the quarter of $9.3 million and
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, through its Higi service and in collaboration with the Michigan Center for Rural Health (MCRH), is proud to announce the successful completion of its 18-month Remote Patient Monitoring (RPM) pilot program designed to enhance healthcare delivery in three rural Michigan hospitals. The pilot, funded by the Michigan Health Endowment Fund's 2022 Special Projects and Emerging Ideas Initiative, was implemented with the goal of increasing digital health capacity and access to care for the
Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the third quarter 2024 ended September 30, 2024, on Wednesday, November 6, 2024, after the market closes. Modivcare will host a conference call on Thursday, November 7, 2024, at 8:30 a.m. Eastern Time to discuss third quarter 2024 financial results. The conference call dial-in number for domestic callers is (888) 437-3179, and international callers should dial +1 (862) 298-0702. Interested parties may a